Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Calorie restriction extends lifespan and produces a metabolic profile desirable for treating diseases of ageing such as type 2 diabetes. SIRT1, an NAD+-dependent deacetylase, is a principal modulator of pathways downstream of calorie restriction that produce beneficial effects on glucose homeostasis and insulin sensitivity. Resveratrol, a polyphenolic SIRT1 activator, mimics the anti-ageing effects of calorie restriction in lower organisms and in mice fed a high-fat diet ameliorates insulin resistance, increases mitochondrial content, and prolongs survival. Here we describe the identification and characterization of small molecule activators of SIRT1 that are structurally unrelated to, and 1,000-fold more potent than, resveratrol. These compounds bind to the SIRT1 enzyme-peptide substrate complex at an allosteric site amino-terminal to the catalytic domain and lower the Michaelis constant for acetylated substrates. In diet-induced obese and genetically obese mice, these compounds improve insulin sensitivity, lower plasma glucose, and increase mitochondrial capacity. In Zucker fa/fa rats, hyperinsulinaemic-euglycaemic clamp studies demonstrate that SIRT1 activators improve whole-body glucose homeostasis and insulin sensitivity in adipose tissue, skeletal muscle and liver. Thus, SIRT1 activation is a promising new therapeutic approach for treating diseases of ageing such as type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, we show that recently developed SIRT1 activators, which are effective in improving energy homeostasis and decreasing hepatosteatosis in mouse models (Milne et al. 2007;Feige et al. 2008), also increase ubiquitination and proteasomal targeting of SREBP-1a, resulting in decreased SREBP-1 nuclear levels and target gene expression.”
From Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP (2010) · cites this paper as Milne et al. 2007
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent studies have reported the identification of potent SIRT1-activating compounds, and showed that such SIRT1 activators could significantly ameliorate insulin resistance and improve energy homeostasis in mouse diet-induced obesity models (Milne et al. 2007).”
From Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP (2010) · cites this paper as Milne et al. 2007
In the citing paper
“In contrast to these negative regulators of insulin action, SIRT1 appears to be a positive regulator of insulin sensitivity (43,44).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [43]
In the citing paper
“Additionally, the non-naturally occurring sirtuin-activating compound, SRT1720, has enhanced insulin sensitivity and oxidative metabolism in animal models of obesity, in part, by improving mitochondrial oxidative capacity231.”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [231]
In the citing paper
“Other related small molecules are more potent than resveratrol to enhance the action of SIRT1 on substrates for deacetylation (218). These compounds also improve insulin sensitivity in obese rodents (218).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [218]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Self-citationLagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Self-citationSmall molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Self-citationTranscriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
Kaeberlein, M., McVey, M., & Guarente, L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2570 · Cited by 2,253
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase
Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., Howitz, K. T., Gorospe, M., de Cabo, R., & Sinclair, D. A. (2004) · Science · doi:10.1126/science.1099196 · Cited by 1,924
Self-citationSirtuin activators mimic caloric restriction and delay ageing in metazoans
Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., & Sinclair, D. (2004) · Nature · doi:10.1038/nature02789 · Cited by 1,868
Self-citation
Research works printed but not linked: 1
- Banks A, et al. Overexpression of the Sirtuin SIRT1 increases insulin sensitivity in aging mice. Diabetes. 2007;56(S1):0234-OR. [Google Scholar]
Cited by
Items 101–200 of 1,004
Sundaresan, N. R., Pillai, V. B., Wolfgeher, D., Samant, S., Vasudevan, P., Parekh, V., Raghuraman, H., Cunningham, J. M., Gupta, M., & Gupta, M. P. (2011) · Science Signaling · doi:10.1126/scisignal.2001465 · Cited by 348
Sirtuins mediate mammalian metabolic responses to nutrient availability
Chalkiadaki, A., & Guarente, L. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.225 · Cited by 346
Jiang, M., Wang, J., Fu, J., Du, L., Jeong, H., West, T., Xiang, L., Peng, Q., Hou, Z., Cai, H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2558 · Cited by 345
“Small compounds with Sirt1 activation activity have been shown to be beneficial in experimental animals prone to metabolic diseases 41 , and development of Sirt1 activators with high specificity and bioavailability may also be a promising approach for the treatment of Huntington’s disease.”
Kitada, M., Kume, S., Imaizumi, N., & Koya, D. (2011) · Diabetes · doi:10.2337/db10-0386 · Cited by 345
“RSV has also been shown to reduce elevated blood glucose levels and metabolic impairment in diabetes, to be associated with mitochondrial biogenesis through the AMPK/SIRT1 activation pathway, as discussed above (12,13,43).”
BackgroundResveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells
Ungvari, Z., Labinskyy, N., Mukhopadhyay, P., Pinto, J. T., Bagi, Z., Ballabh, P., Zhang, C., Pacher, P., & Csiszar, A. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00375.2009 · Cited by 341
“Since resveratrol activates the NAD -dependent protein deacetylase silent information regulator 2/sirtuin 1 (SIRT1) (21, 25) and SIRT1 regulates numerous proteins [including peroxisome proliferator-activated receptor coactivator-1 (PGC-1 )] implicated in the regulation of cellular energetics and mitochondrial function…”
BackgroundOu, X., Lee, M. R., Huang, X., Messina‐Graham, S., & Broxmeyer, H. E. (2014) · STEM CELLS · doi:10.1002/stem.1641 · Cited by 336
“SIRT1 has been considered as a potential therapeutic target for several diseases, such as cancer, Alzheimer's, diabetes and atherosclerosis [27, 28].”
BackgroundFlavonoid Apigenin Is an Inhibitor of the NAD+ase CD38
Escande, C., Nin, V., Price, N. L., Capellini, V., Gomes, A. P., Barbosa, M. T., O’Neil, L., White, T. A., Sinclair, D. A., & Chini, E. N. (2013) · Diabetes · doi:10.2337/db12-1139 · Cited by 332
“Resveratrol (16) and SRT1720 (33) are two of the early SIRT1-activating compounds that improve metabolism and protect against metabolic disorders, although there is a debate about their mechanism of action (34 – 36).”
BackgroundSelf-citationT Cell Replicative Senescence in Human Aging
P. Chou, J., & B. Effros, R. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213805219711 · Cited by 323
SIRT1, Is It a Tumor Promoter or Tumor Suppressor?
Deng, C.-X. (2009) · International Journal of Biological Sciences · doi:10.7150/ijbs.5.147 · Cited by 321
“Similarly, SRT1720, a more potent and specific agonist in activating SIRT1 than resveratrol [52], mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation [49].”
BackgroundThorne, N., Inglese, J., & Auld, D. S. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.05.012 · Cited by 315
“Recently, the activity of compounds thought to enhance the affinity of the human deacetylase SIRT1 for an acetylated p53 peptide (Howitz et al., 2003; Milne et al., 2007) have been shown to be confounded by the fluorescent-tag on the peptide used in the primary assays (Kaeberlein et al.”
BackgroundSirt1 activation protects the mouse renal medulla from oxidative injury
He, W., Wang, Y., Zhang, M.-Z., You, L., Davis, L. S., Fan, H., Yang, H.-C., Fogo, A. B., Zent, R., Harris, R. C., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41563 · Cited by 317
Self-citationDifferential susceptibility to obesity between male, female and ovariectomized female mice
Hong, J., Stubbins, R. E., Smith, R. R., Harvey, A. E., & Núñez, N. P. (2009) · Nutrition Journal · doi:10.1186/1475-2891-8-11 · Cited by 314
Structure and Biochemical Functions of SIRT6
Pan, P. W., Feldman, J. L., Devries, M. K., Dong, A., Edwards, A. M., & Denu, J. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.218990 · Cited by 310
SIRT6 protects against pathological damage caused by diet‐induced obesity
Kanfi, Y., Peshti, V., Gil, R., Naiman, S., Nahum, L., Levin, E., Kronfeld‐Schor, N., & Cohen, H. Y. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2009.00544.x · Cited by 311
“Such molecules have been developed for SIRT1, and are able to mimic the protective effect of overexpressing SIRT1 against obesity-induced physiological damage (Baur et al., 2006; Lagouge et al., 2006; Milne et al., 2007; Feige et al., 2008).”
BackgroundModulation of endogenous antioxidant system by wine polyphenols in human disease
Rodrigo, R., Miranda, A., & Vergara, L. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.11.034 · Cited by 306
Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming
Ong, A. L. C., & Ramasamy, T. S. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.02.004 · Cited by 301
Ladiwala, A. R. A., Lin, J. C., Bale, S. S., Marcelino-Cruz, A. M., Bhattacharya, M., Dordick, J. S., & Tessier, P. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.133108 · Cited by 297
de Kreutzenberg, S. V., Ceolotto, G., Papparella, I., Bortoluzzi, A., Semplicini, A., Man, C. D., Cobelli, C., Fadini, G. P., & Avogaro, A. (2010) · Diabetes · doi:10.2337/db09-1187 · Cited by 301
“In Zucker fa/fa rats, hyperinsulinemic-euglycemic clamp studies demonstrate that SIRT1 activators improve whole-body glucose homeostasis and insulin sensitivity in adipose tissue, skeletal muscle, and liver (31).”
BackgroundLi, Y., Xu, S., Giles, A., Nakamura, K., Lee, J. W., Hou, X., Donmez, G., Li, J., Luo, Z., Walsh, K., et al. (2011) · The FASEB Journal · doi:10.1096/fj.10-173492 · Cited by 297
“Moreover, the small molecular activators of SIRT1, including resveratrol and SRT1720, improve glucose homeostasis and insulin sensitivity in T2DM mice (19– 22).”
BackgroundCaito, S., Rajendrasozhan, S., Cook, S., Chung, S., Yao, H., Friedman, A. E., Brookes, P. S., & Rahman, I. (2010) · The FASEB Journal · doi:10.1096/fj.09-151308 · Cited by 294
SRT1720 improves survival and healthspan of obese mice
Minor, R. K., Baur, J. A., Gomes, A. P., Ward, T. M., Csiszar, A., Mercken, E. M., Abdelmohsen, K., Shin, Y.-K., Canto, C., Scheibye-Knudsen, M., et al. (2011) · Scientific Reports · doi:10.1038/srep00070 · Cited by 293
“2) and with data reported previously in diet-induced obese mice 11 .”
InfluentialSelf-citationSirtuin 1 in lipid metabolism and obesity
Schug, T. T., & Li, X. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.547211 · Cited by 292
“Furthermore, activation of SIRT1 by the polyphenol resveratrol and several synthetic pharmacologic activators has been shown to protect against high-fat induced obesity and metabolic derangements (35-37).”
BackgroundTseng, P.-C., Hou, S.-M., Chen, R.-J., Peng, H.-W., Hsieh, C.-F., Kuo, M.-L., & Yen, M.-L. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.460 · Cited by 291
“One of the most interesting and novel molecular targets of resveratrol is SIRT1, a member of the sirtuin family of nicotinamide adenine dinucleotide (NADþ)–dependent deacetylases, which is found to be an antiaging gene.((8,14,15)) SIRT1 deacetylates various transcription factors in the nucleus such as p53,((16,17)) cl…”
BackgroundPhosphorylation Regulates SIRT1 Function
Sasaki, T., Maier, B., Koclega, K. D., Chruszcz, M., Gluba, W., Stukenberg, P. T., Minor, W., & Scrable, H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0004020 · Cited by 290
“Treatment of obese mice with resveratrol, a pharmacological activator of SIRT1, modestly but significantly improved longevity and, perhaps more importantly, offered some protection against the development of type 2 diabetes mellitus and metabolic syndrome [14–16].”
BackgroundNakagawa, T., & Guarente, L. (2011) · Journal of Cell Science · doi:10.1242/jcs.081067 · Cited by 288
“Consistent with these results, compounds that are able to activate SIRT1, such as resveratrol and SRT1720, protect mice from HFD-induced metabolic disorders (Baur et al., 2006; Feige et al., 2008; Lagouge et al., 2006; Milne et al., 2007).”
ResultThe type III histone deacetylase Sirt1 is essential for maintenance of T cell tolerance in mice
Zhang, J., Lee, S.-M., Shannon, S., Gao, B., Chen, W., Chen, A., Divekar, R., McBurney, M. W., Braley-Mullen, H., Zaghouani, H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38902 · Cited by 287
“Also, Sirt1 activators have been successfully used for treatment of type 2 diabetes (57).”
BackgroundSirtuins and Type 2 Diabetes: Role in Inflammation, Oxidative Stress, and Mitochondrial Function
Kitada, M., Ogura, Y., Monno, I., & Koya, D. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00187 · Cited by 288
“Among the sirtuins, several SIRT1 activators, such as resveratrol and synthesized activators, have been evaluated for their antidiabetic effects in animal models (93).”
BackgroundA Molecular Mechanism for Direct Sirtuin Activation by Resveratrol
Gertz, M., Nguyen, G. T. T., Fischer, F., Suenkel, B., Schlicker, C., Fränzel, B., Tomaschewski, J., Aladini, F., Becker, C., Wolters, D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049761 · Cited by 283
“Sirt5 (this study) and Sirt1 [23,24] is in fact consistent with the”
InfluentialSIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential
Kitada, M., & Koya, D. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.5.315 · Cited by 282
“Numerous reports demonstrate the effects of resveratrol on the improvement of metabolic disorders in ob/ob, db/ db, and high fat diet-induced obese mice or Zucker fa/fa rats [15,54].”
BackgroundPilot study of resveratrol in older adults with impaired glucose tolerance
Crandall, J. P., Oram, V., Trandafirescu, G., Reid, M., Kishore, P., Hawkins, M., Cohen, H. W., & Barzilai, N. (2012) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glr235 · Cited by 281
Targeting the AMPK pathway for the treatment of Type 2 diabetes
Viollet, B. (2009) · Frontiers in Bioscience · doi:10.2741/3460 · Cited by 278
Lifespan and healthspan extension by resveratrol
Bhullar, K. S., & Hubbard, B. P. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.01.012 · Cited by 274
“Importantly, overexpression of SIRT1 has been demonstrated to guard against Alzheimer's disease [52, 53], cancer [41,54], type II diabetes [55], and cardiovascular disease [18,56].”
BackgroundSirt1 Inhibits Oxidative Stress in Vascular Endothelial Cells
Zhang, W., Huang, Q., Zeng, Z., Wu, J., Zhang, Y., & Chen, Z. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/7543973 · Cited by 272
“In addition, there are several other naturally polyphenols, for instance, fisetin and butein that activate Sirt1 [25].”
BackgroundSirtuins in Epigenetic Regulation
Jing, H., & Lin, H. (2015) · Chemical Reviews · doi:10.1021/cr500457h · Cited by 270
The Sirtuin family: therapeutic targets to treat diseases of aging
Milne, J. C., & Denu, J. M. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.01.019 · Cited by 271
Self-citationFunctions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology
Kumar, S., & Lombard, D. B. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1458071 · Cited by 269
“However, resveratrol is a well-known activator of SIRT1 and also exhibits SIRT3 inhibitory activity (Howitz et al. 2003; Milne et al. 2007; Gertz et al. 2012; Lakshminarasimhan et al. 2013).”
BackgroundMitochondrial (Dys)function in Adipocyte (De)differentiation and Systemic Metabolic Alterations
De Pauw, A., Tejerina, S., Raes, M., Keijer, J., & Arnould, T. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.081155 · Cited by 270
“Indeed, one such a mimetic, SRT1720, was able to protect against DIO as well as genetic obesity by enhancing mitochondrial oxidative capacity in metabolic tissues.(122,123) Although the cellular and molecular effects of resveratrol and its mimetics were primarily examined in liver, BAT, and muscle, functional effects…”
BackgroundCalabrese, V., Cornelius, C., Mancuso, C., Pennisi, G., Calafato, S., Bellia, F., Bates, T. E., Giuffrida Stella, A. M., Schapira, T., Dinkova Kostova, A. T., et al. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9775-9 · Cited by 268
“In one study, the shortening of lifespan by the high fat diet was reversed [110].”
BackgroundZhang, F., Liu, J., & Shi, J.-S. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.03.043 · Cited by 264
“Sirt1, one of the silent information regulator 2 (Sir2)-related enzymes, widely exits in the brain, fat, kidney, muscle and liver (Milne et al., 2007).”
BackgroundDose-Dependency of Resveratrol in Providing Health Benefits
Mukherjee, S., Dudley, J. I., & Das, D. K. (2010) · Dose-Response · doi:10.2203/dose-response.09-015.mukherjee · Cited by 263
“2006; Pearson et al. 2008; Lagouge et al. 2006; Milne et al. 2007).”
Epigenetics of Aging and Aging-related Disease
Brunet, A., & Berger, S. L. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu042 · Cited by 264
“These compounds represent an epigenetic interventional path to prevent and treat diseases of aging, thereby extending healthspan in humans (22).”
BackgroundObesity in Type 1 Diabetes: Pathophysiology, Clinical Impact, and Mechanisms
Corbin, K. D., Driscoll, K. A., Pratley, R. E., Smith, S. R., Maahs, D. M., Mayer-Davis, E. J., & Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON) (2018) · Endocrine Reviews · doi:10.1210/er.2017-00191 · Cited by 262
Nicotinamide-induced Mitophagy
Jang, S.-Y., Kang, H. T., & Hwang, E. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.363747 · Cited by 262
“lows: fisetin (3,7,3 ,4 -tetrahydroxyflavone), which is structurally and functionally similar to resveratrol and therefore suffers from the problem of off-target effects (38, 39), and SRT1720, which is known to be highly specific to SIRT1 (40).”
BackgroundStructural basis for allosteric, substrate-dependent stimulation of SIRT1 activity by resveratrol
Cao, D., Wang, M., Qiu, X., Liu, D., Jiang, H., Yang, N., & Xu, R.-M. (2015) · Genes & Development · doi:10.1101/gad.265462.115 · Cited by 258
“Regardless of the nature of the substrates, it was found that the stimulatory effect of resveratrol requires the presence of an N-terminal domain (NTD) in addition to the catalytic domain (CD) of SIRT1 (Milne et al. 2007; Hubbard et al. 2013).”
BackgroundChowanadisai, W., Bauerly, K. A., Tchaparian, E., Wong, A., Cortopassi, G. A., & Rucker, R. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.030130 · Cited by 259
Snyder, S. A., Breazzano, S. P., Ross, A. G., Lin, Y., & Zografos, A. L. (2009) · Journal of the American Chemical Society · doi:10.1021/ja806183r · Cited by 259
Sirtuins, Cell Senescence, and Vascular Aging
Kida, Y., & Goligorsky, M. S. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.11.022 · Cited by 256
SIRT1 contributes to telomere maintenance and augments global homologous recombination
Palacios, J. A., Herranz, D., De Bonis, M. L., Velasco, S., Serrano, M., & Blasco, M. A. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201005160 · Cited by 253
“Furthermore, several SIRT1 direct and indirect activators, including resveratrol, have been recently described to have beneficial effects on several age-associated diseases (Baur et al., 2006; Lagouge et al., 2006; Milne et al., 2007; Feige et al., 2008; Pearson et al., 2008; Yamazaki et al., 2009).”
Human trials exploring anti-aging medicines
Guarente, L., Sinclair, D. A., & Kroemer, G. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.12.007 · Cited by 244
Self-citationChemical probes for histone-modifying enzymes
Cole, P. A. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.111 · Cited by 250
“The particularly potent compound SRT1720, with EC50=160 nM, displayed the ability to stimulate Sir2 by lowering the acetylated peptide substrate Km.(39) An allosteric model is proposed in which SRT1720 and analogs interact with the protein's Nterminus, based on studies analyzing a series of Sir2 deletion mutants.”
BackgroundEsser, N., Paquot, N., & Scheen, A. J. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.974804 · Cited by 250
“In Zucker fa/fa rats, hyperinsulinemic-euglycemic clamp studies demonstrated that SIRT1 activators improve whole-body glucose homeostasis and insulin sensitivity in adipose tissue, skeletal muscle and liver [166].”
BackgroundYao, H., & Rahman, I. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.10.022 · Cited by 250
“…and resveratrol inhibited pro-inflammatory mediators release in response to cigarette smoke exposure (Rajendrasozhan et al., 2008b) suggesting modulation of SIRT1 with activators or endogenous regulators (Milne et al., 2007; Milne and Denu, 2008) would be an approach for the intervention of COPD.”
BackgroundChoi, S., Fu, T., Seok, S., Kim, D., Yu, E., Lee, K., Kang, Y., Li, X., Kemper, B., & Kemper, J. K. (2013) · Aging Cell · doi:10.1111/acel.12135 · Cited by 249
“In addition to resveratrol, SIRT1 is also activated by synthetic compounds, including SRT1720 (Milne et al., 2007; Feige et al., 2008).”
BackgroundSirtuin catalysis and regulation
Feldman, J. L., Dittenhafer-Reed, K. E., & Denu, J. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.378877 · Cited by 248
Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes
Cantó, C., Sauve, A. A., & Bai, P. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.01.004 · Cited by 246
“SRT1720 is structurally different from resveratrol and acts as a more potent and efficient SIRT1 activator (Milne et al., 2007).”
BackgroundCaloric restriction mimetics: towards a molecular definition
Madeo, F., Pietrocola, F., Eisenberg, T., & Kroemer, G. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4391 · Cited by 245
Skeletal muscle mitochondria as a target to prevent or treat type 2 diabetes mellitus
Hesselink, M. K. C., Schrauwen-Hinderling, V., & Schrauwen, P. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.104 · Cited by 242
White adipose tissue mitochondrial metabolism in health and in obesity
Heinonen, S., Jokinen, R., Rissanen, A., & Pietiläinen, K. H. (2020) · Obesity Reviews · doi:10.1111/obr.12958 · Cited by 240
Uittenbogaard, M., & Chiaramello, A. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140305224906 · Cited by 239
Guan, Y., Wang, S.-R., Huang, X.-Z., Xie, Q.-H., Xu, Y.-Y., Shang, D., & Hao, C.-M. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016040385 · Cited by 238
Lin, Z., & Fang, D. (2013) · Genes & Cancer · doi:10.1177/1947601912475079 · Cited by 237
Saunders, L. R., Sharma, A. D., Tawney, J., Nakagawa, M., Okita, K., Yamanaka, S., Willenbring, H., & Verdin, E. (2010) · Aging · doi:10.18632/aging.100176 · Cited by 237
“Similar to resveratrol, small-molecule activators of SIRT1 mimic the beneficial effects of CR and protect mice against age-related diseases [17-18].”
BackgroundNicotinamide Phosphoribosyltransferase (Nampt): A Link Between NAD Biology, Metabolism, and Diseases
Imai, S.-I. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787185814 · Cited by 235
“the case, the activation of Sirt1 in such cell types by increasing systemic NAD biosynthesis, as well as the use of small chemical Sirt1 activators [50], might be an effective therapeutic approach for the prevention and treatment of age-associated diseases caused by functional deficits in those cell types, such as typ…”
BackgroundSRT 2104 extends survival of male mice on a standard diet and preserves bone and muscle mass
Mercken, E. M., Mitchell, S. J., Martin‐Montalvo, A., Minor, R. K., Almeida, M., Gomes, A. P., Scheibye‐Knudsen, M., Palacios, H. H., Licata, J. J., Zhang, Y., et al. (2014) · Aging Cell · doi:10.1111/acel.12220 · Cited by 235
“In addition, AKT is known to suppress FOXO3 transcriptional activity (Milne et al., 2007), although data presented here do not show alterations in pAKT protein levels after SRT2104 treatment (Fig.”
BackgroundSelf-citationObesity and aging: Molecular mechanisms and therapeutic approaches
Santos, A. L., & Sinha, S. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101268 · Cited by 230
The sirtuin family’s role in aging and age-associated pathologies
Hall, J. A., Dominy, J. E., Lee, Y., & Puigserver, P. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64094 · Cited by 229
“One such small molecule, the pharmaceutically engineered sirtuin-activating compound SRT1720 (39, 40), was”
BackgroundInfluentialA c-Myc–SIRT1 feedback loop regulates cell growth and transformation
Yuan, J., Minter-Dykhouse, K., & Lou, Z. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200809167 · Cited by 232
“Activators of SIRT1 improve cellular mitochondria function and protect mice from metabolic diseases (Baur et al., 2006; Lagouge et al., 2006; Milne et al., 2007).”
BackgroundKwon, H.-S., & Ott, M. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.08.001 · Cited by 229
Chen, C.-W., Koche, R. P., Sinha, A. U., Deshpande, A. J., Zhu, N., Eng, R., Doench, J. G., Xu, H., Chu, S. H., Qi, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3832 · Cited by 228
A protein deacetylase SIRT1 is a negative regulator of metalloproteinase‐9
Nakamaru, Y., Vuppusetty, C., Wada, H., Milne, J. C., Ito, M., Rossios, C., Elliot, M., Hogg, J., Kharitonov, S., Goto, H., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-125468 · Cited by 225
“The mass spectrometrybased assay uses an acetylated peptide substrate based on the sequence of p53, as described previously (23).”
MethodSelf-citationResveratrol inhibits nonalcoholic fatty liver disease in rats
Bujanda, L., Hijona, E., Larzabal, M., Beraza, M., Aldazabal, P., García-Urkia, N., Sarasqueta, C., Cosme, A., Irastorza, B., González, A., et al. (2008) · BMC Gastroenterology · doi:10.1186/1471-230x-8-40 · Cited by 225
“Other studies have also noted that resveratrol improved insulin sensitivity, lowered plasma glucose, and increased mitochondrial capacity in obese mice [27].”
Small-Molecule Allosteric Activators of Sirtuins
Sinclair, D. A., & Guarente, L. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134657 · Cited by 223
“Consistent with this idea, deuterium-exchange measurements reveal that the highest degree of folding across SIRT1 is in the conserved domain and in residues 188–245, the proposed activation site (80, 81).”
BackgroundInfluentialSelf-citationOxidative Stress and Epigenetic Regulation in Ageing and Age-Related Diseases
Cencioni, C., Spallotta, F., Martelli, F., Valente, S., Mai, A., Zeiher, A., & Gaetano, C. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140917643 · Cited by 223
“16 μM), which improves glucose homeostasis and insulin sensitivity in animal models of type 2 diabetes [99].”
BackgroundAlrob, O. A., Sankaralingam, S., Ma, C., Wagg, C. S., Fillmore, N., Jaswal, J. S., Sack, M. N., Lehner, R., Gupta, M. P., Michelakis, E. D., et al. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu156 · Cited by 221
Molecular mechanism of endothelial and vascular aging: implications for cardiovascular disease
Camici, G. G., Savarese, G., Akhmedov, A., & Lüscher, T. F. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv587 · Cited by 223
“Additionally, in rats, resveratrol improves whole-body glucose homeostasis and insulin sensitivity in adipose tissue, skeletal muscle, and liver.(68) However, these promising findings obtained in preclin-”
BackgroundInfluentialTurning enzymes ON with small molecules
Zorn, J. A., & Wells, J. A. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.318 · Cited by 218
SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis
Stein, S., Lohmann, C., Schäfer, N., Hofmann, J., Rohrer, L., Besler, C., Rothgiesser, K. M., Becher, B., Hottiger, M. O., Borén, J., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq107 · Cited by 188
“Given the availability of specific SIRT1-activating drugs that are being tested in clinical trials in patients with type 2 diabetes, pharmacological activation of SIRT1 may also become an attractive anti-atherogenic strategy by preventing macrophage foam cell formation.(47)”
Crystallographic structure of a small molecule SIRT1 activator-enzyme complex
Dai, H., Case, A. W., Riera, T. V., Considine, T., Lee, J. E., Hamuro, Y., Zhao, H., Jiang, Y., Sweitzer, S. M., Pietrak, B., et al. (2015) · Nature Communications · doi:10.1038/ncomms8645 · Cited by 212
Self-citationKey proteins and pathways that regulate lifespan
Pan, H., & Finkel, T. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.771915 · Cited by 215
“Administration of these agents also appears to protect against certain age-related conditions (24).”
BackgroundFoxO1 Mediates an Autofeedback Loop Regulating SIRT1 Expression
Xiong, S., Salazar, G., Patrushev, N., & Alexander, R. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.163667 · Cited by 214
The role of the antioxidant and longevity-promoting Nrf2 pathway in metabolic regulation
Sykiotis, G. P., Habeos, I. G., Samuelson, A. V., & Bohmann, D. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32834136f2 · Cited by 214
“Resveratrol is a phytochemical that has been found to exert a number of health benefits and can extend lifespan in several model organisms in a manner that is comparable to CR [29,30].”
ResultAcker, M. G., & Auld, D. S. (2014) · Perspectives in Science · doi:10.1016/j.pisc.2013.12.001 · Cited by 213
Molecular mechanisms of the cardiovascular protective effects of polyphenols
Andriantsitohaina, R., Auger, C., Chataigneau, T., Étienne-Selloum, N., Li, H., Martínez, M. C., Schini-Kerth, V. B., & Laher, I. (2012) · British Journal of Nutrition · doi:10.1017/s0007114512003406 · Cited by 213
“Polyphenols such as resveratrol activate a NADþ-dependent protein deacetylase, silent information regulator orthologue 1 (SIRT1)((145)), which regulates a variety of cellular functions such as genome maintenance, longevity and metabolism((146,147)).”
BackgroundStimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK
Breen, D. M., Sanli, T., Giacca, A., & Tsiani, E. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.104 · Cited by 213
NAD and the aging process: role in life, death and everything in between
Chini, C. C. S., Tarragó, M. G., & Chini, E. N. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.11.003 · Cited by 208
Liu, B., Ghosh, S., Yang, X., Zheng, H., Liu, X., Wang, Z., Jin, G., Zheng, B., Kennedy, B. K., Suh, Y., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.11.007 · Cited by 211
Smith, J. J., Kenney, R. D., Gagne, D. J., Frushour, B. P., Ladd, W., Galonek, H. L., Israelian, K., Song, J., Razvadauskaite, G., Lynch, A. V., et al. (2009) · BMC Systems Biology · doi:10.1186/1752-0509-3-31 · Cited by 186
“Recently, we reported novel small molecule activators of SIRT1 that are 1000 times more potent than resveratrol [32].”
InfluentialSelf-citationLee, D., & Goldberg, A. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.489716 · Cited by 211
Recent advances in obesity-induced inflammation and insulin resistance
Tateya, S., Kim, F., & Tamori, Y. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00093 · Cited by 211
“Sirtuin 1 Sirtuin 1 (SIRT1), the mammalian homolog of yeast silent information-regulator 2 (Sir2), is an NAD-dependent histone deacetylase that has been implicated in the regulation of lifespan under calorie restriction (95) or energy metabolism during fasting (96); thus, it is believed to be a promising target for ty…”
BackgroundSIRT1 Activation by Small Molecules
Dai, H., Kustigian, L., Carney, D., Case, A., Considine, T., Hubbard, B. P., Perni, R. B., Riera, T. V., Szczepankiewicz, B., Vlasuk, G. P., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.133892 · Cited by 211
Self-citationDownregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity
Zhou, B., Li, C., Qi, W., Zhang, Y., Zhang, F., Wu, J. X., Hu, Y. N., Wu, D. M., Liu, Y., Yan, T. T., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2539-8 · Cited by 209
“Resveratrol and its structural analogues, especially SRT1720, also protect mice against highfat diet-induced obesity (DIO) and insulin resistance [13–15].”
BackgroundCrystal Structures of Human SIRT3 Displaying Substrate-induced Conformational Changes
Jin, L., Wei, W., Jiang, Y., Peng, H., Cai, J., Mao, C., Dai, H., Choy, W., Bemis, J. E., Jirousek, M. R., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014928 · Cited by 204
Self-citationThe coordination of nuclear and mitochondrial communication during aging and calorie restriction
Finley, L. W. S., & Haigis, M. C. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.03.003 · Cited by 207
“Recently, SRT1720 has been identified as a specific activator of SIRT1 (Milne et al., 2007; Feige et al., 2008).”
BackgroundRegioselective reactions for programmable resveratrol oligomer synthesis
Snyder, S. A., Gollner, A., & Chiriac, M. I. (2011) · Nature · doi:10.1038/nature10197 · Cited by 207
Resveratrol and related stilbenes: Their anti-aging and anti-angiogenic properties
Kasiotis, K. M., Pratsinis, H., Kletsas, D., & Haroutounian, S. A. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.03.038 · Cited by 205
Transcriptional targets of sirtuins in the coordination of mammalian physiology
Feige, J. N., & Auwerx, J. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.03.012 · Cited by 206
“The pharmacological activation of Sirt1 with natural or synthetic Sirt1 agonists hence could provide an effective mean to combat dietinduced metabolic disorders by indirectly activating PGC-1a-regulated energy expenditure [51 ,52 ,53].”
BackgroundAn overview of Sirtuins as potential therapeutic target: Structure, function and modulators
Wang, Y., He, J., Liao, M., Hu, M., Li, W., Ouyang, H., Wang, X., Ye, T., Zhang, Y., & Ouyang, L. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.10.028 · Cited by 202
Sirtuin-1 Targeting Promotes Foxp3+ T-Regulatory Cell Function and Prolongs Allograft Survival
Beier, U. H., Wang, L., Bhatti, T. R., Liu, Y., Han, R., Ge, G., & Hancock, W. W. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01206-10 · Cited by 203
“Consequently, investigators have sought, respectively, to either induce (14) or suppress (10) its functions.”
BackgroundFang, W.-J., Wang, C.-J., He, Y., Zhou, Y.-L., Peng, X.-D., & Liu, S.-K. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.50 · Cited by 203
Oral Resveratrol Reduces Neuronal Damage in a Model of Multiple Sclerosis
Shindler, K. S., Ventura, E., Dutt, M., Elliott, P., Fitzgerald, D. C., & Rostami, A. (2010) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0b013e3181f7f833 · Cited by 203
“SRT501 is well tolerated in the eye (18), as well as systemically (22).”
BackgroundSelf-citation
Metadata
- Authors
- Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Perni, R. B., Vu, C. B., Bemis, J. E., Xie, R., Disch, J. S., Ng, P. Y., Nunes, J. J., Lynch, A. V., Yang, H., Galonek, H., Israelian, K., Choy, W., Iffland, A., Lavu, S., Medvedik, O., Sinclair, D. A., Olefsky, J. M., Jirousek, M. R., Elliott, P. J., & Westphal, C. H.
- Affiliations
- University of California San Diego (US)
- Harvard University (US)
- Corresponding author
- Westphal, Christoph H.
- ORCID
- Venue
- Nature
- Published
- 2007-11-29
- Volume
- 450
- Issue
- 7170
- Pages
- 712-716
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2753457
- OpenAlex
- W2116350182
- Cited by
- 1,707
- References
- 27
- Citations by year
- 2026: 38 · 2025: 43 · 2024: 55 · 2023: 55 · 2022: 68 · 2021: 100 · 2020: 80 · 2019: 75 · 2018: 82 · 2017: 69 · 2016: 92 · 2015: 89 · 2014: 110 · 2013: 119 · 2012: 126
- FWCI
- 55.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute on Aging (P01AG027916, R01AG028730, R01AG019719)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- SIRT1, small molecule activators, type 2 diabetes, insulin resistance, caloric restriction mimetics, resveratrol, NAD+-dependent deacetylase, allosteric site, glucose homeostasis, mitochondrial function, obesity, aging, drug screening
- MeSH terms
- Resveratrol, Acetylation, Allosteric Site, Animals, Blood Glucose, Cell Line, Diabetes Mellitus, Type 2, Dietary Fats, Disease Models, Animal, Drosophila melanogaster, Heterocyclic Compounds, 4 or More Rings, Humans, Insulin, Male, Mitochondria, Rats, Zucker, Stilbenes, Rats, Sprague-Dawley, Catalytic Domain, Caloric Restriction, Sirtuins, Mice, Rats, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.